- Home
- INCR vs MGRM Comparison
INCR vs MGRM Comparison
Compare INCR & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- MGRM
- Stock Information
- Founded
- INCR 1994
- MGRM 2016
- Country
- INCR Israel
- MGRM United States
- Employees
- INCR N/A
- MGRM N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- MGRM Medical/Dental Instruments
- Sector
- INCR Health Care
- MGRM Health Care
- Exchange
- INCR Nasdaq
- MGRM Nasdaq
- Market Cap
- INCR 76.7M
- MGRM 79.9M
- IPO Year
- INCR N/A
- MGRM N/A
- Fundamental
- Price
- INCR $1.48
- MGRM $2.94
- Analyst Decision
- INCR
- MGRM Strong Buy
- Analyst Count
- INCR 0
- MGRM 1
- Target Price
- INCR N/A
- MGRM $5.40
- AVG Volume (30 Days)
- INCR 19.9K
- MGRM 97.3K
- Earning Date
- INCR 05-06-2025
- MGRM 05-13-2025
- Dividend Yield
- INCR N/A
- MGRM N/A
- EPS Growth
- INCR N/A
- MGRM N/A
- EPS
- INCR N/A
- MGRM N/A
- Revenue
- INCR $72,420,918.00
- MGRM N/A
- Revenue This Year
- INCR N/A
- MGRM N/A
- Revenue Next Year
- INCR $39.30
- MGRM N/A
- P/E Ratio
- INCR N/A
- MGRM N/A
- Revenue Growth
- INCR N/A
- MGRM N/A
- 52 Week Low
- INCR $1.17
- MGRM $1.82
- 52 Week High
- INCR $3.72
- MGRM $4.21
- Technical
- Relative Strength Index (RSI)
- INCR 57.35
- MGRM 58.77
- Support Level
- INCR $1.32
- MGRM $2.50
- Resistance Level
- INCR $1.31
- MGRM $2.74
- Average True Range (ATR)
- INCR 0.07
- MGRM 0.23
- MACD
- INCR 0.03
- MGRM 0.03
- Stochastic Oscillator
- INCR 96.30
- MGRM 83.10
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.